Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

Learn how new agreements aim to lower the cost of weight loss drugs like Wegovy and Zepbound for both insured and uninsured consumers.

(NewsNation) — President Donald Trump is expected to make an announcement Thursday regarding the price of weight loss drugs. Lowering prescription drug prices has been a focus of Trump’s. He ...

The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for those who pay cash for the ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...

Oct 31 (Reuters) - A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix ...

The law, which became effective on July 1, begins regulating prices on Jan. 1. Violates the Commerce Clause of the Constitution: The law attempts to regulate businesses and transactions entirely ...

The Trump administration is expected to announce a deal with two major drug companies to lower the price of their weight-loss drugs. The deal would reduce the costs of the lowest doses of Zepbound and ...

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...